Development of Nucleic‐Acid‐Based Electrochemical Biosensors for Clinical Applications
Nucleic acids are remarkable molecules. In addition to Watson–Crick base pairing, the
different structural motifs of these molecules can bind non‐nucleic acid targets or catalyze …
different structural motifs of these molecules can bind non‐nucleic acid targets or catalyze …
Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
S Fu, P Ping, F Wang, L Luo - Journal of biological engineering, 2018 - Springer
As a family of hormones with pleiotropic effects, natriuretic peptide (NP) system includes
atrial NP (ANP), B-type NP (BNP), C-type NP (CNP), dendroaspis NP and urodilatin, with NP …
atrial NP (ANP), B-type NP (BNP), C-type NP (CNP), dendroaspis NP and urodilatin, with NP …
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
RA Lewis, C Durrington, R Condliffe… - European Respiratory …, 2020 - Eur Respiratory Soc
Despite the advent of new therapies and improved outcomes in patients with pulmonary
arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis …
arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis …
Brain natriuretic peptide and its biochemical, analytical, and clinical issues in heart failure: a narrative review
S Fu, P Ping, Q Zhu, P Ye, L Luo - Frontiers in physiology, 2018 - frontiersin.org
Heart failure (HF) is a primary cause of morbidity and mortality worldwide. As the most
widely studied and commonly applied natriuretic peptide (NP), B-type natriuretic peptide …
widely studied and commonly applied natriuretic peptide (NP), B-type natriuretic peptide …
Recent advances in cardiac biomarkers detection: From commercial devices to emerging technologies
M Savonnet, T Rolland, M Cubizolles, Y Roupioz… - … of Pharmaceutical and …, 2021 - Elsevier
Although cardiac pathologies are the major cause of death in the world, it remains difficult to
provide a reliable diagnosis to prevent heart attacks. Rapid patient care and management in …
provide a reliable diagnosis to prevent heart attacks. Rapid patient care and management in …
Photonic and electrochemical biosensors for near-patient tests–a critical comparison
Research into diagnostic biosensors is a vibrant field that combines scientific challenge with
translational opportunities; innovation in healthcare is of great societal interest and is an …
translational opportunities; innovation in healthcare is of great societal interest and is an …
State of the art of immunoassay methods for B-type natriuretic peptides: An update
A Clerico, M Franzini, S Masotti… - Critical Reviews in …, 2015 - Taylor & Francis
The aim of this review article is to give an update on the state of the art of the immunoassay
methods for the measurement of B-type natriuretic peptide (BNP) and its related peptides …
methods for the measurement of B-type natriuretic peptide (BNP) and its related peptides …
A systematic evaluation of immunoassay point-of-care testing to define impact on patients' outcomes
V Pecoraro, G Banfi, L Germagnoli… - Annals of clinical …, 2017 - journals.sagepub.com
Background Point-of-care testing has been developed to provide rapid test results. Most
published studies focus on analytical performance, neglecting its impact on patient …
published studies focus on analytical performance, neglecting its impact on patient …
Disproportionate mitral regurgitation determines survival in acute heart failure
M Berrill, I Beeton, D Fluck, I John… - Frontiers in …, 2021 - frontiersin.org
Objectives: To assess the prevalence and impact of mitral regurgitation (MR) on survival in
patients presenting to hospital in acute heart failure (AHF) using traditional …
patients presenting to hospital in acute heart failure (AHF) using traditional …
Heart failure biomarkers at point-of-care: current utilization and future potential
ES Christenson, PO Collinson… - Expert Review of …, 2014 - Taylor & Francis
Heart failure (HF) is a prevalent disease that is associated with a high morbidity and
mortality; HF is estimated to cost the US healthcare system over US $39 billion annually …
mortality; HF is estimated to cost the US healthcare system over US $39 billion annually …